Back
Fulcrum Therapeutics Vs. Johnson & Johnson Industry Stock Comparison
Sell
47
FULC
Fulcrum Therapeutics
Last Price:
3.32
Seasonality Move:
67.13%
Sell
39
JNJ
Johnson & Johnson
Last Price:
151.85
Seasonality Move:
1.76%
Sell
47
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.57. The Score for FULC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $153.24. The Score for JNJ is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $153.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 47.89 | Sell |
| Chaikin Money Flow: | -662910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.24 - 3.56) | Buy |
| Bollinger Bands (100): | (3.61 - 8.65) | Sell |
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.2 | Sell |
| Relative Strength Index (14 RSI): | 28.14 | Sell |
| Chaikin Money Flow: | 5170663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (156.69 - 163.65) | Sell |
| Bollinger Bands (100): | (153.01 - 164.97) | Sell |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.48 | Buy |
| 20-day SMA: | 3.38 | Buy |
| 50-day SMA: | 4.06 | Sell |
| 200-day SMA: | 7.33 | Sell |
| 8-day EMA: | 3.5 | Buy |
| 20-day EMA: | 3.5 | Buy |
| 50-day EMA: | 4.32 | Sell |
| 200-day EMA: | 6.19 | Sell |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 155.95 | Sell |
| 20-day SMA: | 159.8 | Sell |
| 50-day SMA: | 161.88 | Sell |
| 200-day SMA: | 155.94 | Sell |
| 8-day EMA: | 155.68 | Sell |
| 20-day EMA: | 158.34 | Sell |
| 50-day EMA: | 159.97 | Sell |
| 200-day EMA: | 157.84 | Sell |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.42 per share, and a decrease next year of $0.79 per share.
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.68 per share.
Fulcrum Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Johnson & Johnson Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||